Hemispherx Biopharma, Inc: Highlights
Financial data in U.S. dollars
| Financial Highlights |
|---|
| Sales |
96000.00 |
| Income |
-12.23 Mil |
| Net Profit Margin |
NA |
| Return on Equity |
-30.92% |
| Debt/Equity Ratio |
0.00 |
|
| Revenue/Share |
0.00 |
| Earnings/Share |
-0.13 |
| Book Value/Share |
0.50 |
| Dividend Rate |
0.00 |
| Payout Ratio |
NA |
|
| Revenue - Quarterly Results (in Millions) |
|---|
| | FY (12/09) | FY (12/08) | FY (12/07) |
|---|
| 1st Qtr | 0.0 | 0.2 | 0.3 |
| 2nd Qtr | 0.0 | 0.0 | 0.2 |
| 3rd Qtr | 0.0 | 0.0 | 0.3 |
| 4th Qtr | NA | 0.0 | 0.3 |
| Total | 0.1 | 0.3 | 1.1 |
| Earnings Per Share - Quarterly Results |
|---|
| | FY (12/09) | FY (12/08) | FY (12/07) |
|---|
| 1st Qtr | -$0.04 | -$0.04 | -$0.07 |
| 2nd Qtr | -$0.04 | -$0.04 | -$0.05 |
| 3rd Qtr | -$0.02 | -$0.05 | -$0.08 |
| 4th Qtr | NA | -$0.04 | -$0.05 |
| Total | -$0.10 | -$0.17 | -$0.25 |
| Qtr. over Qtr. EPS Growth Rate |
| FY (12/09) | FY (12/08) | FY (12/07) |
|---|
| 1st Qtr | 0% | 20% | --- |
| 2nd Qtr | 0% | 0% | 29% |
| 3rd Qtr | 50% | -25% | -60% |
| 4th Qtr | NA | 20% | 37% |
| Yr. over Yr. EPS Growth Rate |
| FY (12/09) | FY (12/08) |
|---|
| 1st Qtr | 0% | 43% |
| 2nd Qtr | 0% | 20% |
| 3rd Qtr | 60% | 37% |
| 4th Qtr | NA | 20% |
advertisement
Recent News